Current vaccine trials in glioblastoma: a review - Wikidata - awgldk - TriplyDB

Current vaccine trials in glioblastoma: a review

Current vaccine trials in glioblastoma: a review

http://www.wikidata.org/entity/Q26828965

about

CD8 T Cell-Independent Antitumor Response and Its Potential for Treatment of Malignant Gliomas Immune Evasion Strategies of Glioblastoma Stress Response Leading to Resistance in Glioblastoma-The Need for Innovative Radiotherapy (iRT) Concepts The progress of immunotherapy for glioblastoma Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites Polymeric drug delivery for the treatment of glioblastoma Blood brain barrier: a challenge for effectual therapy of brain tumors T1-Weighted Dynamic Contrast-Enhanced MRI as a Noninvasive Biomarker of Epidermal Growth Factor Receptor vIII Status.miR-101 reverses hypomethylation of the PRDM16 promoter to disrupt mitochondrial function in astrocytoma cells Pediatric Brain Tumors: Current Knowledge and Therapeutic Opportunities Recent advances and future of immunotherapy for glioblastoma.Cell line with endogenous EGFRvIII expression is a suitable model for research and drug development purposes.SapC-DOPS nanovesicles: a novel targeted agent for the imaging and treatment of glioblastoma Variant CD44 expression is enriching for a cell population with cancer stem cell-like characteristics in human lung adenocarcinoma.Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives.Investigational new drugs for brain cancer.Peptides as a therapeutic avenue for nanocarrier-aided targeting of glioma.The Safety of available immunotherapy for the treatment of glioblastoma.Tumor Vaccines for Malignant Gliomas.MRI in Glioma Immunotherapy: Evidence, Pitfalls, and Perspectives.Engineering challenges for brain tumor immunotherapy.Biomarkers and therapeutic advances in glioblastoma multiforme.Modulating glioma-mediated myeloid-derived suppressor cell development with sulforaphane.Down-regulation of HSP60 Suppresses the Proliferation of Glioblastoma Cells via the ROS/AMPK/mTOR Pathway.Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme.Immunomodulation Mediated by Anti-angiogenic Therapy Improves CD8 T Cell Immunity Against Experimental Glioma

P2860

Q26740520-683D9F07-3833-453E-9F78-41BBEA1C644A Q26765855-4A807517-E2DF-49E7-8992-EE94345A628B Q26771706-9DDDEDEB-1AF7-44AE-AA6F-82218D44FBC4 Q26797282-B239E18B-8666-4A3E-8638-E4D7C728A946 Q26798402-2984720C-05EF-4BE9-AA89-B9B9082F74FA Q27010046-897A5456-7C01-4C13-8A44-30FBC2FB7C69 Q28081947-927940E7-02C0-44A5-A9EF-19F8C61F1FCA Q36494583-6DB88288-D5A2-4293-8664-5BC891DFF6A0 Q36782656-E2D65A8C-FD05-4B52-A612-BDDE37C15C8A Q37213305-C9035AF3-7D70-4439-BD05-917009B8C255 Q37239071-69AA83F3-98ED-424B-BC8D-105A4C3F894A Q37362563-FC25A194-48C1-4612-96D9-057D44051A24 Q38414026-A888EF8E-D173-428E-B473-8545D17320C1 Q38694662-B96F5487-954F-4630-940B-297CD0D41823 Q38743138-65BA1CE6-ECCB-4C49-B458-90DA63CEA61B Q38832510-651223D2-4F0D-4A8B-860B-7FFD1E9E84A2 Q38969029-59B66400-20F2-493F-8598-A3DE29C70E96 Q39042442-6D1609CD-BB8C-499A-BDC9-8B2AEE0E7448 Q39228039-61CF4F7D-D5CB-4B4D-8E61-54997C1BD1B1 Q39312420-A853C9EB-0C76-497C-8540-393AE59A331B Q39381281-CF741777-1E64-4AB1-BB17-3D8032901A78 Q40070524-5624B716-1122-4DA8-B989-5EC8FB31EB4F Q40987646-93E2AF91-FF53-4308-8529-A26AF6B3E6CD Q42578957-D1D498D8-5E76-467F-90A0-AF9A6F90EFA3 Q55278851-E21953C4-B2B3-4745-B357-F3BA43C4733F Q58733930-08DAE154-ED34-4CAA-8D59-3952A8053726

P2860

Current vaccine trials in glioblastoma: a review

http://www.wikidata.org/entity/Q26828965

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Current vaccine trials in glioblastoma: a review

@ast

Current vaccine trials in glioblastoma: a review

@en

Current vaccine trials in glioblastoma: a review

@nl

type

label

Current vaccine trials in glioblastoma: a review

@ast

Current vaccine trials in glioblastoma: a review

@en

Current vaccine trials in glioblastoma: a review

@nl

prefLabel

Current vaccine trials in glioblastoma: a review

@ast

Current vaccine trials in glioblastoma: a review

@en

Current vaccine trials in glioblastoma: a review

@nl

P1433

Q26828965-90FED62E-A0E3-4F4E-9616-DE40779AA484

P1476

Q26828965-5F5F4A0C-1D6B-4A48-9A44-34A2FE4E40B1

P2093

Q26828965-5DF6D882-8F39-468D-9DD1-64C3793D80D5

Q26828965-D208603E-A5EA-416A-AA1B-20A96B956790

P275

Q26828965-A75CA661-DBF8-45B5-B0A3-ED33F8A8945A

P2860

Q26828965-031D59CB-76C6-4AAD-8D36-35F0BB23746D

Q26828965-07C210FA-21D6-4A6A-9468-659807A35B5A

Q26828965-09820CB0-3B48-4A75-AFA3-200AEC08933C

Q26828965-10B2FCC5-BF93-4CF2-AA16-176D98733F9B

Q26828965-12C000B8-3618-4902-844D-53531003CC5F

Q26828965-1BE1B2EB-20F4-4663-8C2B-58E822659203

Q26828965-1FB31C2F-EB97-4054-886D-BDF6B2EA7CCE

Q26828965-24754842-EBDA-4C6A-80F7-2C550ABC662C

Q26828965-25020844-5B72-4705-92C5-48B66059FE69

Q26828965-26E2AD2F-A355-4270-A673-48B13EFFB5CC

P304

Q26828965-B4A480E3-64EB-4B03-BA29-709FFEE89D9F

P31

Q26828965-139965AD-EB11-4A43-A701-7F17AF21B5C3

Q26828965-462810F3-C24B-4A60-AA7B-3F0F27FC327A

P3181

Q26828965-F86326C2-9423-40E3-9E3A-7075D4653833

P356

Q26828965-A52EED33-B419-4FDB-9FC4-B443D36F7F41

P407

Q26828965-5EF72577-C5EC-4139-B24A-EBE7B98943AA

P478

Q26828965-E3712485-CF4F-4E78-AA0E-AE165AD8B427

P50

Q26828965-079B1C03-F564-4C4D-8994-E6D7CEBC5289

Q26828965-EF78923D-9120-4F8A-B303-D9852DADC383

P5008

Q26828965-2E84F1D9-C69F-4379-ABAA-C45D11DFCBFB

P577

Q26828965-67424513-A67E-4C7A-8641-D1EB2EBE8DEB

Q26828965-B4801264-E0AD-4E0E-9E99-024957C97773

P5875

Q26828965-80CF2C77-A1E3-4BB5-A983-28090C659E5B

P698

Q26828965-5C0241B8-8804-4F26-A4BF-F98E6EEF49C0

P921

Q26828965-70A5E701-F7FA-4D6D-82ED-116999129D88

Q26828965-8970BCDF-ED7C-45EA-A35D-D5D128CD9B65

Q26828965-AD8894B6-E7D4-46DB-A78C-8757A7224634

Q26828965-D2AB0A63-438C-4AA7-86E0-2C638829ABDB

P932

Q26828965-8DB48FC0-3291-4BD4-A525-9114B6D16D48

P3181

P356

P1433

Journal of Immunology Research

P1476

Current vaccine trials in glioblastoma: a review

@en

P2093

Kevin K H Chow

http://www.w3.org/2001/XMLSchema#string

Linda W Xu

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

Consensus on the role of human cytomegalovirus in glioblastoma

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Identification of a cancer stem cell in human brain tumors

Identification of a novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor alpha2 chain

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

P304

796856

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4279316

http://www.w3.org/2001/XMLSchema#string

P356

10.1155/2014/796856

http://www.w3.org/2001/XMLSchema#string

P407

P478

2014

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2014-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262114134

http://www.w3.org/2001/XMLSchema#string

P698

24804271

http://www.w3.org/2001/XMLSchema#string

P921

biomedical investigative technique

P932

3996322

http://www.w3.org/2001/XMLSchema#string